Bioxyne Limited (BXN.AX)
Bioxyne Limited operates in the Packaged Foods industry of the Consumer Defensive sector, headquartered in Sydney, NSW, AU. The stock last traded at $0.93, up 0.00% on the session, giving a market capitalisation of $213.9M. Its beta of 0.65 implies it has historically moved less than the broad market.
Headquartered in Sydney, Australia, Bioxyne Limited is a life sciences and health company established in 1998. The firm dedicates itself to the research, development, marketing, and distribution of nutritional supplements and beauty products. Its operations are divided into wholesale and direct sales segments, reaching customers online, through partners, and directly across the United States and Asia. Bioxyne's diverse product line includes functional foods and cosmetic solutions, notably Progastrim for digestive and immune wellness, Progastrim plus Vitamin C for cold symptom relief, and proTract, specifically formulated for infant eczema (atopic dermatitis).
Bioxyne Limited is most often compared with the following Consumer Defensive names: